Adobe Systems Incorporated today announced that SAFE-BioPharma Association has certified Adobe Acrobat software, Adobe Reader with Adobe LiveCycle Reader Extensions and Adobe LiveCycle Document Security software for compliance the with the SAFE digital signature standard. These are the first software products ever certified by SAFE, a non-profit association that manages digital identity and signature standards for pharmaceutical industries.
With today’s announcement, legally binding digital signatures are more readily available to biopharmaceutical professionals who need help eliminating the inefficiencies and inaccuracies of paper-based processes while improving end-to-end electronic document workflows. By using the Adobe products certified by SAFE, biopharmaceutical organizations, clinical investigators and regulators can collaborate more securely and efficiently to better service patients, conduct pharmaceutical research, and help bring new drugs to market more quickly.
“SAFE congratulates Adobe on being the first company to invest in our certification program. We expect these readily available certified products to accelerate use of SAFE digital signatures in the pharmaceutical industry,” said Mollie Shields-Uehling, President and Chief Executive Officer, SAFE-BioPharma Association.